AZTA

Azenta, Inc.

$40.48

-1.15%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space.

Source: Yahoo Finance
AI summary

Price & performance

1M+4.8%
3M+32.5%
YTD+4.3%
1Y+12.5%
52-week range—
Beta1.44
Full chart and returns against a benchmark

Q-Score

48/ 100

Quality against peers; 50 is the peer median.

Growth45
Risk51
Performance40
Valuation59
Profitability50
Leverage72
Sentiment20
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$593.8M+3.6%
Net income-$55.8M
Net margin-9.4%+19.4 pts
Historical fundamentals

Red flags in filings

3active red flags
Material weakness in controlsDec 4, 2025
Late filing noticeDec 2, 2025
Material impairmentOct 7, 2026
Filings, findings and the timeline

Valuation

AZTAIndustryP/E—49.36P/S2.893.73EV/EBITDA—23.12P/B1.173.92PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 10next report, after the close
EPS estimate$0.13
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate